Company Overview of Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The company develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. Ceptaris Therapeutics, Inc. was formerly known as Yaupon Therapeutics, Inc. and changed its name to Ceptaris Therapeutics, Inc. in January 2012. The company was founded in 2002 and is based in Malvern, Pennsylvania. As of September 19, 2013, Ceptaris Therapeutics, Inc. operates as a subsidiary of Actelion US Holding Company.
101 Lindenwood Drive
Malvern, PA 19355
Founded in 2002
Key Executives for Ceptaris Therapeutics, Inc.
Similar Private Companies By Industry
|G1 Therapeutics, Inc.||United States|
|Ortho Biologics LLC||United States|
|Endo Pharmaceuticals Solutions Inc.||United States|
|Nutrilite Health Institute||United States|
|Good 'n' Natural Manufacturing Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ceptaris Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.